To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Jessica Skarzynski
The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer. 
Ryan McDonald
More than half of the patients (61%) admitted to either the hospital or ICU were discharged and 12% remained in the hospital. Nine patients had died by the time data collection was cut off for this study.
Debu Tripathy, M.D.
Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.
Mike Hennessy Sr., Chairman and Founder
In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.
Cancer Research Institute
Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.
Amy Paturel
Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.
Beth Fand Incollingo
A new tool analyzes patterns of RNA expressed from genes, pinpointing more patients with cancer who can benefit from immunotherapies and targeted drugs.
Arlene Weintraub
New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.
Hannah Slater
Immunotherapy with Keytruda shows promise in advanced uncommon cancers in which new treatment options are needed.
Key opinion leaders close the discussion by considering the future of cutaneous squamous cell carcinoma (CSCC) and promising emerging regimens.

Sign In

Not a member? Sign up now!
Continue without login